This ACC/AHA focused update provides evidence-based recommendations for perioperative beta-blocker therapy in patients undergoing noncardiac surgery.
Answers are grounded in this paper and cite their sources.
Adopt these evidence-graded recommendations for perioperative beta blockade now; extends prior ACC/AHA guidance for noncardiac surgery.
In Brief The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines makes every effort to avoid any actual, potential, or perceived conflict of interest that might arise as a result of an industry relationship or personal interest of the writing committee. Specifically, all members of the writing committee, as well as peer reviewers of the document, were asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing committee at each meeting, and updated and reviewed by the writing committee as changes occur. Please see Appendix 1 for author relationships with industry and Appendix 2 for peer reviewer relationships with industry. These guidelines attempt to define practices that meet the needs of most patients in most circumstances. These guideline recommendations reflect a consensus of expert opinion after a thorough review of the available, current scientific evidence and are intended to improve patient care. If these guidelines are used as the basis for regulatory/payer decisions, the ultimate goal is quality of care and serving the patient’s best interests. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient. Sidney C. Smith, Jr., MD, FACC, FAHA Chair, ACC/AHA Task Force on Practice Guidelines Elliot M. Antman, MD, FACC, FAHA Immediate Past-Chair, ACC/AHA Task Force on Practice Guidelines IMPLICATIONS: These Guidelines, published by the American Heart Association/American College of Cardiology, discuss the available literature on perioperative beta blockade for noncardiac surgery and define recommendations with the strength of evidence. By identifying Class I recommendations, the Guidelines may have implications with relation to pay-forperformance or pay-for-reporting activities. The AHA/ACC agree that patient care is our highest priority, and all decisions must be made by the provider and the patient, taking into consideration all circumstances presented by the particular patient.
No takes yet. Share an insight, caveat, or question.
Fleisher et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: